SCHEMBL2345504

SCHEMBL2345504

COC(=O)CCCCCCCCCCCC(C)C

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.58
L3MBTL1 Q9Y468 1/20 0.57
LMNA P02545 4/20 0.52
ALDH1A1 P00352 1/20 0.52
KDM4C Q9H3R0 2/20 0.49
KDM4A O75164 1/20 0.49
PHF8 Q9UPP1 1/20 0.49
KDM2A Q9Y2K7 1/20 0.49
PABPC1 P11940 1/20 0.45
APOBEC3A P31941 1/20 0.45
APOBEC3G Q9HC16 1/20 0.45
KMT2A Q03164 1/20 0.43
PPARG P37231 1/20 0.42
RECQL P46063 1/20 0.42
CA12 O43570 1/20 0.42
CA7 P43166 1/20 0.42
CA9 Q16790 1/20 0.42
CA14 Q9ULX7 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2260424 1.00 TSHR (0.58) TSHRL3MBTL1LMNAALDH1A1KDM4C
SCHEMBL17506460 1.00 TSHR (0.58) TSHRL3MBTL1LMNAALDH1A1KDM4C
SCHEMBL19281392 1.00 TSHR (0.58) TSHRL3MBTL1LMNAALDH1A1KDM4C
SCHEMBL1369686 1.00 TSHR (0.58) TSHRL3MBTL1LMNAALDH1A1KDM4C
SCHEMBL19281389 1.00 TSHR (0.58) TSHRL3MBTL1LMNAALDH1A1KDM4C
SCHEMBL19281387 1.00 TSHR (0.58) TSHRL3MBTL1LMNAALDH1A1KDM4C
SCHEMBL5056126 1.00 TSHR (0.58) TSHRL3MBTL1LMNAALDH1A1KDM4C
SCHEMBL2254699 1.00 TSHR (0.58) TSHRL3MBTL1LMNAALDH1A1KDM4C
SCHEMBL19281377 1.00 TSHR (0.58) TSHRL3MBTL1LMNAALDH1A1KDM4C
SCHEMBL19281385 1.00 TSHR (0.58) TSHRL3MBTL1LMNAALDH1A1KDM4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119846099-A Nail metabolism marker, marker combination and application for diagnosing Alzheimer disease 重庆医科大学 2025-04-18 CN claimed
CN-113499334-B Wild jujube fruit antibacterial sensitization active refined substance and preparation method and application thereof 延安大学 2022-06-24 CN claimed
CN-113499334-A Wild jujube fruit antibacterial sensitization active refined substance and preparation method and application thereof 延安大学 2021-10-15 CN claimed
CN-1282730-A Compounds with particular structure and anticancer activity and its preparing process YANG ZHENHUA (CN) 2001-02-07 CN claimed
CN-119846099-A Nail metabolism marker, marker combination and application for diagnosing Alzheimer disease 重庆医科大学 2025-04-18 CN disclosed
US-20240382574-A1 METHODS AND COMPOSITIONS FOR ORALLY DOSING ANIMALS Animal Science Products, Inc. (US) 2024-11-21 US disclosed
US-12097180-B2 Swine maternal neonatal pheromone TEXAS TECH UNIVERSITY SYSTEM (US) 2024-09-24 US disclosed
US-12097181-B2 Swine maternal neonatal pheromone TEXAS TECH UNIVERSITY SYSTEM (US) 2024-09-24 US disclosed
US-20240084343-A1 METHODS OF USING NATURAL AND ENGINEERED ORGANISMS TO PRODUCE SMALL MOLECULES FOR INDUSTRIAL APPLICATION KIVERDI INC (US) 2024-03-14 US disclosed
EP-4282972-A2 PRODUCTION OF BRANCHED CHAIN FATTY ACIDS AND DERIVATIVES THEREOF IN RECOMBINANT MICROBIAL CELLS Genomatica, Inc. (US) 2023-11-29 EP disclosed
US-20220354823-A1 SWINE MATERNAL NEONATAL PHEROMONE TEXAS TECH UNIVERSITY SYSTEM (US) 2022-11-10 US disclosed
CN-113499334-B Wild jujube fruit antibacterial sensitization active refined substance and preparation method and application thereof 延安大学 2022-06-24 CN disclosed
CN-1193002-C Compounds with particular structure and anticancer activity and its preparing process YANG ZHENHUA (CN) 2005-03-16 CN disclosed
EP-1075533-A4 SMALL MOLECULE ANTICANCER COMPOUNDS AND RELATED PRODUCTION PROCESS YANG ZHENHUA (US) 2005-03-09 EP disclosed
CN-1108796-C Use of anticancer material and production method of said anti-cancer material YANG ZHENHUA (CN) 2003-05-21 CN disclosed
US-6214875-B1 ADMINISTERING FATTY ACID YANG ZHENHUA (US) 2001-04-10 US disclosed
EP-1075533-A1 SMALL MOLECULE ANTICANCER COMPOUNDS AND RELATED PRODUCTION PROCESS Yang, Zhenhua (US) 2001-02-14 EP disclosed
CN-1282730-A Compounds with particular structure and anticancer activity and its preparing process YANG ZHENHUA (CN) 2001-02-07 CN disclosed
CN-1251296-A Use of anticancer material and production method of said anti-cancer material YANG ZHENHUA (CN) 2000-04-26 CN disclosed
WO-1999053086-A1 SMALL MOLECULE ANTICANCER COMPOUNDS AND RELATED PRODUCTION PROCESS YANG ZHENHUA (US) 1999-10-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12097180-B2 Swine maternal neonatal pheromone PIGS, KISS1R, PGF TSHR 3919/4885L3MBTL1 767/4885LMNA 2301/4885
US-12097181-B2 Swine maternal neonatal pheromone PIGS, KISS1R, PGF TSHR 3919/4885L3MBTL1 767/4885LMNA 2301/4885
US-20220354823-A1 SWINE MATERNAL NEONATAL PHEROMONE PIGS, KISS1R, PGF TSHR 3919/4885L3MBTL1 767/4885LMNA 2301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.